Implanta
Who owns Implanta?
Implanta was owned by Argos Wityu through Argos Fund VI (2015 vintage) from 2014 to 2020.
Hand-verified · updated 2026-06-10
More from Argos Fund VI
Other portfolio companies in the same fund.
More PE-backed in Healthcare
Comparable healthcare deals from other GPs.
Save this record to your watchlist and pick up your research where you left off. No spam.
About Implanta
Implanta, formerly known as Odonto Group, is a Milan-based dental services group that operates across public and private hospitals and clinics, principally in Northern Italy. The company offers a complete range of odontostomatological care, spanning hygiene, implantology, pedodontics, gnathology and orthodontics, delivered to hospital-class clinical standards that allow it to treat patients with critical co-morbidities. Its structure combines an in-house dental laboratory with a network of more than ten satellite companies located in Italy and Switzerland. According to company and investor disclosures, Implanta employs roughly 80 people and was founded in Milan in 1994.
Ownership journey
Implanta was founded in Milan in 1994 and built up over the following two decades into a conglomerate dental group operating inside hospitals and clinics, supported by its own laboratory and a cluster of satellite entities in Italy and Switzerland. In 2014 Argos Wityu invested in the company through its Argos Fund VI, in what the firm described as its first healthcare-services transaction and its eleventh deal in Italy. The sponsor held the business through the second half of the decade and exited in 2020 via a trade sale.
Under PE ownership
The 2014 investment was structured as growth capital to consolidate a complex, conglomerate group that combined a state-of-the-art in-house laboratory with more than ten satellite companies spread across Italy and Switzerland. Under Argos Wityu's ownership the platform continued to operate a full range of dental services, from hygiene through to implantology, positioned around hospital-class standards and the ability to handle clinically complex patients. The holding ran through to 2020, when the sponsor exited via a trade sale, closing a roughly six-year investment period.
Who could buy Implanta?
6 strategic and 114financial buyers match this company's sector and geography profile, ranked from verified European deal history.
Find likely buyersGet the full record on Implanta.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Already a member? Sign in